VolitionRx Limited Amortization of Intangible Assets
VolitionRx Limited (VNRX) reported Amortization of Intangible Assets of $12.32 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-13
- VolitionRx Limited amortization of intangible assets for the quarter ending 2026-06-30 was $6.15K, a 2.26% increase year-over-year.
- VolitionRx Limited amortization of intangible assets for the quarter ending 2026-03-31 was $6.17K, a 2.58% increase year-over-year.
- VolitionRx Limited amortization of intangible assets for the quarter ending 2025-06-30 was $6.01K.
- VolitionRx Limited amortization of intangible assets for the quarter ending 2025-03-31 was $6.02K, a 57.91% decline year-over-year.
- VolitionRx Limited amortization of intangible assets for fiscal 2025 was $24.01K.
- VolitionRx Limited amortization of intangible assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VolitionRx Limited amortization of intangible assets for fiscal 2023 was $84.91K, a 12.38% increase from fiscal 2022.
- VolitionRx Limited amortization of intangible assets for fiscal 2022 was $75.56K, a 17.55% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $12.32K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $6.17K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $24.01K 10-K · filed 2026-03-31 | |||
| 2025-06-30 | $6.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $12.03K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $6.02K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | |||
| 2024-03-31 | $14.29K 10-Q · filed 2024-05-13 | $35.49K derived: sum of 2 quarters · filed 2025-03-31 | $56.81K derived: sum of 3 quarters · filed 2025-03-31 | $78.08K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | $21.20K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $42.52K derived: sum of 2 quarters · filed 2025-03-31 | $63.78K derived: sum of 3 quarters · filed 2025-03-31 | $84.91K 10-K · filed 2025-03-31 |
| 2023-09-30 | $21.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $42.59K derived: sum of 2 quarters · filed 2023-11-14 | $63.72K 10-Q · filed 2023-11-14 | $76.99K derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-06-30 | $21.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $42.39K 10-Q · filed 2023-08-14 | $55.66K derived: sum of 3 quarters · filed 2024-05-13 | $75.30K derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-03-31 | $21.13K 10-Q · filed 2024-05-13 | $34.40K derived: sum of 2 quarters · filed 2024-05-13 | $54.04K derived: sum of 3 quarters · filed 2024-05-13 | $74.80K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $13.27K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $32.91K derived: sum of 2 quarters · filed 2024-03-25 | $53.67K derived: sum of 3 quarters · filed 2024-03-25 | $75.56K 10-K · filed 2024-03-25 |
| 2022-09-30 | $19.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $40.40K derived: sum of 2 quarters · filed 2023-11-14 | $62.29K 10-Q · filed 2023-11-14 | $84.52K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $20.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $42.65K 10-Q · filed 2023-08-14 | $64.88K derived: sum of 3 quarters · filed 2023-08-14 | $87.72K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $21.89K 10-Q · filed 2023-05-10 | $44.12K derived: sum of 2 quarters · filed 2023-05-10 | $66.97K derived: sum of 3 quarters · filed 2023-05-10 | $90.24K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $22.23K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $45.08K derived: sum of 2 quarters · filed 2023-03-15 | $68.35K derived: sum of 3 quarters · filed 2023-03-15 | $91.64K 10-K · filed 2023-03-15 |
| 2021-09-30 | $22.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $46.12K derived: sum of 2 quarters · filed 2022-11-14 | $69.41K 10-Q · filed 2022-11-14 | $92.47K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $23.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $46.57K 10-Q · filed 2022-08-10 | $69.63K derived: sum of 3 quarters · filed 2022-08-10 | $92.36K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $23.29K 10-Q · filed 2022-05-11 | $46.35K derived: sum of 2 quarters · filed 2022-05-11 | $69.09K derived: sum of 3 quarters · filed 2022-05-11 | $90.50K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $23.06K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $45.80K derived: sum of 2 quarters · filed 2022-03-30 | $67.21K derived: sum of 3 quarters · filed 2022-03-30 | $88.63K 10-K · filed 2022-03-30 |
| 2020-09-30 | $22.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $44.15K derived: sum of 2 quarters · filed 2021-11-10 | $65.57K 10-Q · filed 2021-11-10 | $87.09K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $21.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $42.83K 10-Q · filed 2021-08-11 | $64.35K derived: sum of 3 quarters · filed 2021-08-11 | $86.33K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $21.42K 10-Q · filed 2021-05-11 | $42.94K derived: sum of 2 quarters · filed 2021-05-11 | $64.93K derived: sum of 3 quarters · filed 2021-05-11 | $86.60K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $21.52K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $43.51K derived: sum of 2 quarters · filed 2021-03-22 | $65.18K derived: sum of 3 quarters · filed 2021-03-22 | $87.28K 10-K · filed 2021-03-22 |
| 2019-09-30 | $21.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $43.66K derived: sum of 2 quarters · filed 2020-11-12 | $65.76K 10-Q · filed 2020-11-12 | $88.09K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $21.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $43.78K 10-Q · filed 2020-08-13 | $66.11K derived: sum of 3 quarters · filed 2020-08-13 | $88.83K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $22.10K 10-Q · filed 2020-05-07 | $44.43K derived: sum of 2 quarters · filed 2020-05-07 | $67.15K derived: sum of 3 quarters · filed 2020-05-07 | $90.33K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $22.33K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $45.05K derived: sum of 2 quarters · filed 2020-02-20 | $68.23K derived: sum of 3 quarters · filed 2020-02-20 | $91.91K 10-K · filed 2020-02-20 |
| 2018-09-30 | $22.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $45.90K derived: sum of 2 quarters · filed 2019-11-12 | $69.58K 10-Q · filed 2019-11-12 | $92.40K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $23.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $46.86K 10-Q · filed 2019-08-12 | $69.67K derived: sum of 3 quarters · filed 2019-08-12 | $92.44K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $23.68K 10-Q · filed 2019-05-08 | $46.49K derived: sum of 2 quarters · filed 2019-05-08 | $69.26K derived: sum of 3 quarters · filed 2019-05-08 | $90.76K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $22.81K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $45.58K derived: sum of 2 quarters · filed 2019-03-13 | $67.07K derived: sum of 3 quarters · filed 2019-03-13 | $87.99K 10-K · filed 2019-03-13 |
| 2017-09-30 | $22.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $44.26K derived: sum of 2 quarters · filed 2018-11-07 | $65.18K 10-Q · filed 2018-11-07 | $86.33K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $21.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $42.42K 10-Q · filed 2018-08-13 | $63.57K derived: sum of 3 quarters · filed 2018-08-13 | $85.33K derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $20.92K 10-Q · filed 2018-05-10 | $42.07K derived: sum of 2 quarters · filed 2018-05-10 | $63.84K derived: sum of 3 quarters · filed 2018-05-10 | $85.83K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $21.15K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $42.92K derived: sum of 2 quarters · filed 2018-03-01 | $64.91K derived: sum of 3 quarters · filed 2018-03-01 | $86.46K 10-K · filed 2018-03-01 |
| 2016-09-30 | $21.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $43.76K derived: sum of 2 quarters · filed 2017-11-09 | $65.31K 10-Q · filed 2017-11-09 | $86.73K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $21.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $43.55K 10-Q · filed 2017-08-10 | $64.97K derived: sum of 3 quarters · filed 2017-08-10 | $86.67K derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $21.55K 10-Q · filed 2017-05-11 | $42.97K derived: sum of 2 quarters · filed 2017-05-11 | $64.68K derived: sum of 3 quarters · filed 2017-05-11 | $86.28K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $21.42K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $43.13K derived: sum of 2 quarters · filed 2017-03-10 | $64.73K derived: sum of 3 quarters · filed 2017-03-10 | $85.90K 10-K · filed 2017-03-10 |
| 2015-09-30 | $21.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $43.31K derived: sum of 2 quarters · filed 2016-11-10 | $64.48K 10-Q · filed 2016-11-10 | $86.87K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $21.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $42.77K 10-Q · filed 2016-08-11 | $65.16K derived: sum of 3 quarters · filed 2016-08-11 | $88.86K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $21.17K 10-Q · filed 2016-05-13 | $43.56K derived: sum of 2 quarters · filed 2016-05-13 | $67.26K derived: sum of 3 quarters · filed 2016-05-13 | $91.69K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $22.39K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $46.09K derived: sum of 2 quarters · filed 2016-03-11 | $70.52K derived: sum of 3 quarters · filed 2016-03-11 | $95.04K 10-K · filed 2016-03-11 |
| 2014-09-30 | $23.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $48.13K derived: sum of 2 quarters · filed 2014-11-06 | $72.65K 10-Q · filed 2014-11-06 | $101.92K derived: sum of 4 quarters · filed 2015-03-18 |
| 2014-06-30 | $24.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $48.95K 10-Q · filed 2014-08-01 | $78.22K derived: sum of 3 quarters · filed 2015-03-18 | $106.89K derived: sum of 4 quarters · filed 2015-03-18 |
| 2014-03-31 | $24.52K 10-Q · filed 2014-05-15 | $53.79K derived: sum of 2 quarters · filed 2015-03-18 | $82.45K derived: sum of 3 quarters · filed 2015-03-18 | $110.80K derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-12-31 | $29.28K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $57.94K derived: sum of 2 quarters · filed 2015-03-18 | $86.28K derived: sum of 3 quarters · filed 2015-03-18 | $114.88K 10-K · filed 2015-03-18 |
| 2013-09-30 | $28.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $57.01K derived: sum of 2 quarters · filed 2013-10-31 | $85.60K 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $28.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $56.94K 10-Q · filed 2013-07-29 | ||
| 2013-03-31 | $28.60K 10-Q · filed 2013-05-06 | |||
| 2012-12-31 | $112.06K 10-K · filed 2014-03-28 | |||
| 2011-12-31 | $107.64K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |